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Two  distinct  T  helper  cell  (Th) ~ populations  are  required  to  induce  B  cells  to 
produce optimal amounts of antibody (1-6). The hypothesis that these two Th have 
different effects on B cells, i.e., that Thl is mainly responsible for quantitative effects, 
whereas Th2 determines the qualitative aspects of antibody formation is supported by 
the work of Rohrer and his associates (manuscript in preparation) in their studies on 
the effects of Th on the activity of MOPC-315 myeloma cells. They have shown that 
the two Th affect the myeloma cells in different ways. The first Th causes an increase 
in proliferation of the myeloma cells and the second an increase in their secretion of 
paraprotein. The Th for proliferation expresses a different phenotype (Lyt-1 +2-; Qa- 
1-)  than  the Th for secretion  (Lyt-l+2-; Qa-l+). These data show that there are at 
least two steps in the differentiation of B cells. 
The generation of alloantigen-specific cytotoxic T  lymphocyte effector cells (CTL) 
is similar to the induction of antibody forming cells, in that T  cell help is required for 
optimal induction of CTL from CTL precursors (CTL-P) (7). We have asked whether 
CTL might also be similar to B cells in the existence of two steps in the development 
of CTL, perhaps influenced by a distinct Th at each step. To do this we have inhibited 
the induction  of CTL in allogeneic mixed leukocyte culture  (MLC)  by treating the 
cultures with the drug pyrilamine (8) or by using heat-inactivated stimulator cells (9). 
We have found that either of these treatments can block the generation of CTL while 
allowing CTL-P to differentiate from a naive state (CTL-PN) into an activated state 
(CTL-PA). CTL-PA can be distinguished  from CTL-PN by the fact that the former 
can  develop into  CTL  in  the  face of levels of T  cell-mediated  suppression,  which 
inhibit the production of CTL from CTL-PN. Thus, the generation of CTL is a two- 
step process. Step 1, which is the induction of CTL-PN to CTL-PA, is sensitive to the 
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effects of in vitro generated suppressor T  cells (T,), but is not inhibited by addition to 
culture of pyrilamine or heat inactivation of stimulator cells. On the other hand, step 
2, the differentiation of CTL-PA to CTL, can be blocked by pyrilamine, but not by 
the same suppressor cells that  inhibit the transition from CTL-PN to CTL-PA. The 
CTL-PA to CTL step and, possibly the CTL-PN to CTL-PA step, require Th activity• 
Materials and Methods 
Animals.  Male C57BL/6 (B6) (H-2 b, Tby- 1.2 ÷, Lye- 1.2*,2.2+,3.2  ÷) BALB/c (H-2d), DBA/2 
(H-20), CBA (H-2k), C3H/He (H-2k,Thy-l.2  +) and AKR/J (H-2k,Thy-l.I) mice, 6-8 wk of 
•  "  "  n  age were  obtained from  The Jackson  Laboratory. Bar  Harbor,  ME.  B6.PLThyl  mice  (  - 
b  ÷  +  "~  +  •  "  2 ,Thy-l.l  Lyt-l.2  ,2.2  ,3.2 ) are Thy-1 congentc B6 mice bred by Dr. Donal Murphy of the 
Yale Medical School  or in the Cancer Center breeding colonies at Tufts University. All mice 
were rested for at least  I wk in our animal facilities before use. 
In Vitro Induction of  CTL.  Induction and assay of CTL were performed as described previously 
(10).  Briefly,  single-cell  suspensions of spleen cells  were  washed  three  times  in  phosphate- 
buffered balanced salt solution (BSS) containing 5% fetal bovine serum (BSS-FBS). CTL were 
generated  in  2  ml  MLC  in 24-well  tissue  culture plates  (76-033-05,  Linbro Scientific Co., 
Hamden, CT). 5 ×  106 viable responding spleen cells were incubated with 5 ×  10  ~ allogeneic 
stimulator spleen cells in modified MisbelI-Dutton plating medium containing 10% FBS  (1 I, 
12), in an atmosphere of 5% CO~ in humidified air at  37°C. Stimulators were  prepared by 
incubating 5  ×  10  7  viable splenic lymphoid cells  in  1 ml of BSS-FBS  containing 30/~g of 
mitomycin C (Sigma Chemical Co., St. Louis, MO) for  1 h at 37°C. 
The cells were then washed three times in BSS-FBS, diluted in plating medium, and added 
to culture wells• After 4-6 d, cells were harvested by repeated agitation using a pasteur pipette• 
Before transfer or assessment  of CTL activity, cells were washed once, unless pyrilamine (vzde 
mfra) had been added to the culture, in which case they were washed three times. 
l~rzlammt Ma&ate.  Pyrilamine, a histaminel receptor antagonist (Sigma Chemical Co.), was 
added  to 4-6-d MLC at  the time of culture initiation• Addition of  1 X  10 -4  M  pyrilamine 
generally resulted in a decrease  in viable cell yields from  the usual 60-70% to  15-30% of the 
cells originally placed in culture• 
Assay of CTL Function.  CTL were assayed  on the basis of MLC yield equivalents. That is, 
three or more wells per group, incubated as described above, were harvested, washed, pooled, 
counted, and diluted in BSS-FBS so that the viable cell concentration was usually 8 ×  106 to 
1 X  10  7 per ml for the highest  concentration of the effectors  tested (i.e., a 40: 1-50:1  effector/ 
target  cell  ratio)•  Threefold  and  ninefold dilutions were  also  tested  in  most  cases,  using 
quadruplicate microwells per  dilution, per  group.  In  certain  instances, equal  numbers of 
effectors  treated in different ways were compared for cytotoxicity. I00 p.l of each effector  cell 
suspension was  added  to  100 #1  containing 2  ×  104  5~CrNa~CrO4 (New  England Nuclear, 
Boston,  MA)  -labeled target  cells  (see below), in 96-well  fiat-bottomed tissue  culture plates 
(3040,  Falcon Labware, Oxnard, CA). Cells were sedimented by centrifugation of the trays, 
which were  then incubated for 4 h at  37°C. Subsequently, a  100-/el supernatant sample was 
obtained from each well and assayed for gamma counts. Target cells for CTL assay  included 
cultured  DBA/2  mastocytoma P815  (H-2  a)  cells,  or,  alternatively, 3-  or  4-d  thioglycolate- 
induced peritoneal exudate cells  (PEC)  from  CBA  or  DBA/2  mice.  The  latter  cells  were 
depleted of erythrocytes by hypotonic lysis before SlCr labeling. 
Analysis of Data.  Cytotoxicity assays  were  always performed in quadruplicate• Release of 
~tCr into the supernatant by killer cells was compared with release from target cells incubated 
either with medium (0% or spontaneous release)  or with 2% Triton X-100 (Amersham Corp•, 
Arlington Heights, IL)  (100% release).  Spontaneous (0%) release  usually varied from  10% to 
25%  of Triton X-100  controls.  When  significant cytotoxicity  (that  is,  ~20%  release)  was 
detected,  the  standard  deviation  (SD)  was  generally _<10% of the  mean  release.  Because 
multiple effector  dilutions were  tested  for  cytotoxicity, it  was  possible,  in each  experiment 
presented, to compare groups under conditions in which  killing was  linear function of the 
effector cell number. Only such data are presented. 
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similarly to CTL. Briefly,  5 ×  l0  s male B6 or B6.PLThyl" (H-2  b) responder spleen cells were 
cultured with 5 ×  105 mitomycin  C-treated male allogeneic (H-2  d) stimulator spleen cells for 4- 
6 d in the presence or absence of 10  4  M  pyrilamine. In some cases, stimulator Ceils Were not 
mitomyein CI treated, but were beat inactivated at 450C for 60 rain and 2 X  107 (preheating 
viable cell number; usually, 50%~60% of the cells were dead after this treatment) were incubated 
with 2  X  107 viable responder cells in  10,ml  flask  cultures (3050,  Costar,  Data  Packaging, 
Cambridge, MA) according to method of Burton et al. (9). The putative suppressor cells and 
CTL-PA were then washed and transferred to a 5-d second MLC in which B6 or B6.PLThyl" 
spleen cells were responders. The use of Thy-1-different congenic B6 responder cells in the first 
and second cultures allowed us to determine, at assay, the MLC from which CTL were derived. 
This was accomplished by treating cells harvested from second cultures with the appropriate 
anti-Thy-1 serum and rabbit complement (C') before CTL assay. The percentage suppression 
of CTL generation was calculated by the formula: percent suppression ~=  100 -  (percent SlCr 
release with suppressors  +  percent 5XCr release with no suppressors).  For example, to estimate 
the relative activity of B6- vs. B6.PLThyl'-derived CTL in a  mixture of the two cell types, 
anti-Thy-1.2  serum + C'-resistant percent 5tCr release (i.e., B6~PLThy I" derived) was subtracted 
from  pooled  normal  mouse  serum  (NMS)  +  C'-resistant  percent  5tCr  release  (B6  and 
B6.PLThy 1" derived). 
Antiserum Treatment of Lymphoid Cells.  Fresh spleen cells or spleen cells harvested from MLC 
were washed three times. They were then treated at 0°C for 30 rain with NMSI allogeneic anti- 
Thy-1.2 serum (AKR/J-anti-C3H/He serum, kindly provided by Dr. Charles Janeway of Yale 
University), diluted  1:40  in  BSS-FBS  or  with  rat-anti-mouse Thy-l.2 hybridoma culture 
supernatant (kindly provided by Dr. Michael Iverson of Yale University) at a  1:50 dilution of 
stock.  Cells were suspended at a  1 ×  107 per ml maximum concentration in the appropriate 
dilution of the desired anti-Thy-1 reagent. The tubes were incubated for 30 min at 37°C and 
the cells were washed and resuspended in 1 ml of rabbit C' (prescreened for low toxicity and 
depending on the lot, diluted from 1  : 10 to 1  : 16 as indicated by titration) and incubated 35 min 
at 37°C with shaking. Subsequently, cells were washed twice, counted for viable cell yield, and 
assayed for either CTL-P or effector  function, or for suppressive capability. It is noteworthy 
that both anti-Thy-1 reagents used were completely specific for Thy-l.2 antigen-bearing  cells, 
in that neither reagent, even when used at five times the final concentrations described above, 
had any effect on either the viability or CTL precursor or effector  function of B6.PLThy-1  a 
cells. 
To deplete Lyt-1 ÷ (Ly-I and Ly-123) T lymphocytes, cells were incubated under conditions 
similar to those described above. A  1:1,000 dilution of the anti-Lyt-l.2 hybridoma reagent 
(C3H/Lilly-anti-I-SL-57  clone 22-10.3) kills 68% of anti-immunoglobulin  plate-purified T cells, 
whereas a  1:1,000 dilution of the anti-Lyt-2.2 hybridoma reagent (C3H/fl-anti-ERLD clone 
41-3) kills 50% ofT cells (M. Iverson, personal communication). Both reagents were generously 
supplied by Dr.  F. W. Shen of the Memorial Sloan-Kettering  Cancer Center, New York). 
Preparation of Nylon-nonadherent, Splenic T  Cell-enriched Populations.  Nylon wool  (Leuko-pak, 
Fenwal Laboratories, Div. Travenol Laboratories,  Deerfield,  IL)  was  prepared,  placed  into 
plastic disposable syringes, autoclaved, and used by the method of Julius et  al.  (13).  After 
elution of nonadberent spleen cells from the column, they were concentrated by centrifugation 
and applied, similarly, to a second nylon wool column. Subsequently eluted cells ("twice-passed 
nylon wool nonadberent cells")  were >95% viable. 
Preparation of Glass-nonadherent Spleen Cells.  1 X l0  s- 1.5 x  l0  s spleen cells were added to 100 
X  15 mm Pyrex petri dishes  in  15 ml BSS-FBS.  They were incubated at 37°C for  1 h, after 
which  the  nonadherent cells  were  resuspended  by  gentle swirling and  were  collected  by 
pipetting all fluid. The procedure was repeated in an identical manner using fresh  BSS-FBS 
and fresh petri dishes, yielding "twice-treated glass-nonadherent cells". 
Results 
Effect of Pyrilamine  on  CTL  Induction.  We have previously evaluated the effect  of 
histamine on the generation of CTL  (10).  During these experiments we  discovered 
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tion when added at the start of a  4- or 5-d MLC at a  10  -4 M  concentration. Table I 
exemplifies  the  results  of such  experiments.  More  than  95%  inhibition  of CTL 
generation  was  routinely  obtained  with  a  10  -4  M  concentration  of  pyrilamine, 
associated with a  50-75% decrease in viable cell yield compared with control cultures 
incubated without pyrilamine.  The relationship  of inhibition  of CTL generation  to 
the  "toxic"  effects  of the  drug  is  not  clear,  but  is  not  relevant  to the  studies  that 
follow.  10  -4.5 M  or  10  -5  M  (Table  I),  and  as  low  as  10  -6 M  (data  not  presented) 
pyrilamine  were  also  inhibitory  of CTL  generation  in  a  concentration-dependent 
manner.  The profound  inhibitory  effect  of 10  -4 M  pyrilamine  on CTL  generation 
(used  in  all  further  studies)  persisted  through  at  least  144  h  of culture  (data  not 
presented). 
A  Thy-1 Congenic System for Study of Suppressor Cells and CTL-P.  In other studies  (8) 
we have presented data indicating that pyrilamine inhibits not only CTL generation 
in  MLC,  but  also  the  generation  of nonspeeific  suppressor  T  cells  (T~N),  whereas 
allospecific suppressor T  cell induction (T,S) in MLC is not inhibited. Thus, B6-anti- 
DBA/2 suppressors  (I-I-2b-anti-H-2a), raised in the presence of pyrilamine for 4-6 d, 
could inhibit  CTL g6neration  upon transfer  to fresh,  new B6-anti-DBA/2  cultures 
under  conditions  in  which  they  had  no  suppressive  effect  on  fresh  B6-anti-C3H 
cultures  (H-2b-anti-H-2k). 
In order to simultaneously study T, and CTL-P functions, we have used a  Thy-1 
congenic B6 mouse, two-cuhure system. In the typical protocol, responder cells ~n the 
first MLC are from B6 ('rhy-l.2  +) mice, whereas responder cells in the second (assay) 
MLC are from congenic B6.PLThyl a (Thy-1.1 +) mice. Treatment with anti-Thy-1.2 
serum plus C' of cells harvested after the second MLC then leaves only CTL generated 
in the second MLC  (i.e.,  Thy-l.1 + killers).  We can reverse the Thy-1  phenotype of 
first  and  second culture  responders,  and  the  system works equally  well.  Therefore, 
suppression can be determined accurately by comparing anti-Thy-1.2-resistant  CTL 
activity in suppressed MLC with anti-Thy-1.2-resistant CTL activity in control MLC. 
An example of results obtained with this system is portrayed in Table II. Spleen cells 
of B6 or B6.PLThyl a mice were stimulated  with DBA/2 cells in vitro.  5  d  later the 
TABLE  I 
Pyrilamine Inhibition of Cytotoxic T Cell Generation and Viable Cell 
Yields  fiom MLC* 
Percent 51Cr release (3= SD) at  Effector/  Percent 
viable  Pyrilamine  culture dilutions  target cell  cell  yield 
concentration  ratio undi- 
(molarity)  1:3  Undiluted  luted  per cul- 
ture 
0  45.2 (3.4)  56.7 (2.8)  45:1  48 
10  -s  32.8 (3.0)  48.6 (1.7)  39:1  41 
10  -4.5  19.5 (2.5)  38.9 (2.5)  30:1  32 
10  -4  -0.1 (1.2)  1.3 (1.7)  12:1  15 
* 5 ×  10  0 B6 spleen cells were incubated"  with 5 ×  10  b mitomycin C-treated 
DBA/2 spleen cells for 5 d in the presence or absence of pyrilamine. Cells 
from triplicate cultures per group were then washed three times, pooled and 
diluted equally, and tested for ability to kill SlCr-labeled P815 target ceils in 
quadruplicate  assay cultures per  group. The percent  release due  to B6 
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TABLE  II 
Thy-I Congenic B6 Mouse Spleen Cell Two-culture System  for Evaluation of 
Suppression and of the Culture  fiom  Which CTL Arise* 
Percent 61Cr release (+ SD) 
Serum treatment before  Cells from first  Fresh responders 
MLC  in second MLC  CTL assay 
NMS +  C'  Anti-Thy-l.2 
+ C' 
None  Thy- 1.1 +  45.3 (5.3)  40.4 (2.9) 
None  Thy-l.2  +  38.2 (4.2)  -3.6 (1.5) 
Thy 1.1 +  Thy-l.2  +  51.3 (5.7)  43.5 (2.8) 
Thy 1.2  +  Thy-l.2  +  24.5 (3.0)  -4.8 (3.3) 
Thy 1.2  +  Thy-l.l  +  25.5 (2.5)  2.8 (2.0) 
* First MLC were established in triplicate cultures per group with 5 ×  l0  s B6 
(Thy-l,2  +) or B6.PLThyl" (Thy-l.1  +) responders and 5 ×  105 mitomycin C- 
treated DBA/2 stimulators. 5 d later 5 x  105 viable cells were transferred to 
similar cultures as indicated.  After an additional 5 d, cells harvested  from 
three wells of each group were treated with NMS + C' or with anti-Thy-1.2 
serum + C'. The residual cells were diluted equally in each case, so that the 
results given are using culture-treatment  yield equivalent  numbers of effec- 
tors. 2 ×  104 e*Cr-labeled DBA/2 PF,,C targets were mixed with effectors in 
quadruplicate cultures per group. MLC without transferred cells contained 
effectors at a 45:1 effector/target  cell ratio. Similar results were obtained, in 
the same experiment, using 15:1 and 5:1 effector/target cell ratios. 
cells were washed and transferred to fresh MLC. Cells from such MLC were harvested 
5 d later and were treated with either NMS plus C' or an anti-Thy-l.2 serum plus C', 
and were then evaluated for ability to kill target cells. Treatment of B6-derived CTL 
(to which no suppressors had been added) with anti-Thy-l.2 serum plus C' completely 
prevented killing, whereas similar treatment  had no  significant effect on  killing by 
B6.PLThyl" CTL. When sufficient  (usually ~1  x  105-2 x  l0  n) Thy-l.1 + suppressor 
cells were transferred to Thy-1.2  + second cultures, treatment with anti-Thy-1.2 serum 
plus C' after the second culture had little or no influence on effector function. Thus, 
in  this situation  the CTL  detected were all derived from  the first culture, showing 
that  the  second  culture's  capacity to  generate  CTL  was  severely suppressed.  This 
conclusion was  supported by the  finding that  when  Thy-l.2  +  suppressor cells were 
added to cultures in which the responder cells were either Thy-1.1 + or Thy-l.2  +, all 
CTL  function  detected was  susceptible to  anti-Thy-l.2 serum  plus C'.  These  data 
show that the Thy-1 congenic responder cell system can be used to evaluate suppres- 
sion of CTL  generation, as well as to examine the source and  function of in  vitro- 
induced CTL. 
Effect of Pyrilamine  on  7", and CTL-P Activities.  We have used  the Thy-1  congenic 
responder  cell  system  to  evaluate  the  effects  of pyrilamine on  T,  generation  and 
CTL-P activation. In the experiment portrayed in Table III, B6-anti-DBA/2 MLC 
were  established in  the presence or absence of 10  -4 M  pyrilamine. Harvested cells 
were subsequently transferred to fresh second MLC consisting of B6.PLThyl" respond- 
ers and DBA/2 stimulators. Once again, it can be seen that CTL  that developed in 
control MLC (Thy-1.1 +) without transferred cells were not affected by treatment with 
anti-Thy-l.2  serum  plus  C'  before  assay.  However,  when  B6-anti-DBA/2  MLC- 788  TWO STEPS  IN CYTOTOXIC  T  LYMPHOCYTE  INDUCTION 
TABLE III 
Ability of Pyrilamim-treated MLC-derived Cells to Suppress CTL Generation 
and to Differentiate to CTL Effectors upon Transfer to Fresh MLC* 
Percent SICr Release 
(:1: SD) 
Fresh  Percent 
Cells from first  responders  Serum treatment before  suppression 
MLC  in second  assay  of second 
MLC  MLC 
NMS + C'  Anti-Thy- 
1.2 +  C' 
None  Thy-l.1  +  47.4 (5.5)  47.7 (4.2)  Standard 
Thy-l.2  +  Thy-l.1  +  52.8 (3.2)  2.1 (2.8)  96 
Thy-l.2+:+ P:~  Thy-l.1  +  31.8 (4.0)  -3.1 (1.4)  I06 
* B6-anti-DBA/2 (Thy-l.2*) cultures were established as in legend to Table I. 
After 5 d cells were harvested from triplicate cultures, pooled, washed three 
times, and 2 x  l0  s cells were transferred to six fresh B6.PLThy- 1  a (Thy-1.1+)  - 
anti- DBA/2 second MLC each, as indicated.  After 5 additional d cells in 
these cultures were pooled and divided into two equal aliquots, which were 
treated with either NMS + C' or anti-Thy-l.2 serum + C'. Cells were then 
washed and diluted to an equal volume per group. Given is the percent SlCr 
release for a 22:1 effector/target cell ratio in control cultures (no suppressors), 
using 2 X 104 DBA./2 PEC as targets. 
~: Pyrilamine,  10  -4 M. 
derived cells were transferred to second MLC, essentially all CTL  activity was anti- 
Thy-1.2 serum sensitive. Thus, there was virtually total suppression of CTL generation 
from fresh CTL-PN in the second MLC, and all CTL activity detected arose from the 
first MLC  cells. In  the presence of pyrilamine no CTL  generation occurs.  Even  so, 
when these cells were transferred; total suppression ofCTL  generation in the second 
MLC  occurred,  and  first  culture-derived  CTL  arose:  These  data  show  that  the 
Thy-l-congenic system  allows quantitation  of transferred  CTL-P  activity. As dem- 
onstrated in Table III (1 of > I0 such experiments), the quantity of pyrilamine,treated 
first culture-derived CTL activity was decreased compared with untreated cells. This 
decrease varied from one-third of, to equal to the CTL-function developed in second 
cultures by non-pyrilamine-treated, transferred cells. When pyrilamine-treated MLC- 
derived cells were transferred to fresh MLC which were also treated with pyrilamine, 
no  CTL  activity arose from  either culture  in  three of three experiments  (data not 
presented).  This  shows  that  the  failure  of  CTL-PA  to  differentiate  to  CTL  in 
pyrilamine-treated  cultures  is  not  due  to  deteriorating  culture  conditions.  These 
results demonstrate that (a) CTL-P do not differentiate to CTL in pyrilamine-treated 
cultures; (b) once removed from pyrilamine-treated cultures and placed in fresh MLC, 
CTL-P can differentiate to CTL; and (c) the latter differentiation to CTL is resistant 
to  the  same  suppressive  influences  that  are  capable of completely blocking CTL 
generation by fresh unprimed cells. Therefore, CTL  generation occurs in two steps. 
The first step, a  change from  CTL-PN  to CTL-PA,  is suppressor cell sensitive and 
pyrilamine resistant,  whereas  the  second  step,  CTL-PA  to CTL,  is  suppressor cell 
resistant and pyrflamine sensitive. 
Effect  of Heat  Treatment  of Stimulator  Cells  on  Suppressor  Cell  and  CTL-P  Activation. 
Recently, Burton et al.  (9)have shown that heat .inactivation at 450(3  for 60 min of 
allogeneic cells used as MLC stimulators allows suppressor T  Cell activation, whereas A.  SCHWARTZ,  S.  L.  SUqq'ON,  AND  R.  K.  GERSHON 
T^BLE  IV 
Effect of Heat-inactivated  Stimulator  Cells on Induction of CTL Activity* 
789 
Percent SlCr release (-1- SD) at culture dilutions  Effector/ 
Additions to B6  target cell 
respondera  1:27  1:9  1:3  Undiluted  ratio un- 
diluted 
Experiment 1  6-d culture 
None  ND:[:  0.1  (3.3)  0.2 (4.6)  1.2 (3.8)  ND 
BALB/c-HS  ND  1.5 (3.0)  12.8  (1.6)  31.1  (6.4)  25:1 
BALB/c-Mito  ND  31.5 (4.6)  53.6 (4.6)  68.4 (5.5)  42:1 
Experiment 2  4-d culture 
None  1.2 (4.5)  -0.7 (3.7)  2.3 (3.1)  -0.9 (1.2)  32:1 
DBA/2-HS  0.6 (2.7)  2.6 (2.6)  6.0 (2.8)  15.2 (2.0)  36:1 
DBA/2-mito  17.2 (4.7)  33.7 (5.9)  49.1  (2.5)  48.8 (2.3)  57:1 
DBA/2-mito +  P  -  1.2 (2. I)  -  1.5 (2.9)  -- 1.9 (4.1)  0.2 (3.0)  15:1 
DBA/2-HS +  P  -1.9 (3.8)  -1.7 (2.4)  -2.5  (3.7)  1.3 (1.7)  9:1 
* 2 ×  107 responder spleen cells, with or without 2 X  107 DBA/2 or BALB/c stimulator spleen cells, either 
heated at 45"C for 1 h  (heat stimulator [HS]) or treated with mitomycin C  (mito), were incubated in  10 
ml plating medium, with or without  10  -4 M  pyrilamine (P), for 4  or 6 d. Harvested cells were washed 
three times, counted, and diluted to 0.8 ml (undiluted) each. Therefore, cells were assayed for cytotoxicity 
vs.  P815  target  cells  (2  X  104/weU)  on  a  culture-yield  equivalent  basis.  Given  are  the  results  of 
quadruplicate CTL assay cultures per group. 
:~ Not done. 
T^nLE  V 
Effect of Heating Stimulator  Cells and Addition  of Pyrilamine  to MLC on 
CTL-P and 7"8 Activation* 
Cells from first MLC 
Respond-  Conditions 
Percent S~Cr  release 
(± SD) 
Cell  Fresh 
number  responders  Treatment before CTL 
trans-  in second  assay 
ferred  MLC 
NMS  +  C'  Anti-Thy- 
1.2  +  C' 
--  0  Thy-l.l ÷  49.8 (3.2)  48.7 (2.3) 
Thy-1.2  ÷  HS No P  9 x  105  Thy-l.l ÷  81.4 (5.4)  21.5 (2.5) 
3 ×  10  s  71.4 (3.4)  7.4 (2.8) 
1 x  10  ~  39.5 (I.I)  4.9 (3.0) 
Thy- 1.2  ÷  HS P  9 x  105  Thy-I..l ÷  3.6 (3.l)  1.3 (1.8) 
3 x  105  5.5 (3.0)  -0.3 (3.1) 
1 ×  l0  s  12.6 (3.1)  8.3 (0.8) 
* 2  X  107 B6 (Thy-l.2  ÷) responding spleen cells were incubated for 6  d  in the 
presence or absence of 10  -4 P, with 2  x  107 BALB/c stimulator cells which 
had been heated at 45°12 for  1 h  (HS).  The suppressors were washed three 
time*  and  were  transferred  to  fresh  triplicate  second  MLC  of 5  X  l0  s 
B6.PLThy-I"  (Thy-l.l+)  responders  and  5  X  l0  s  mitomycin  C-treated 
BALB/c stimulators. After 5 d, cultures were harvested, pooled, and divided 
into two equal aliquots, one of which was treated with NMS +  C' and the 
other with rat anti-mouse Thy-l.2 hybridoma supernatant +  C'. Given are 
the results obtained from quadruplicate CTL assay cultures per group. 790  TWO STEPS IN CYTOTOXIC T  LYMPHOCYTE INDUCTION 
CTL effector generation  in  inhibited.  As  in  our earlier studies  (8),  this  also  gave 
evidence that  CTL effector function per  se  is  not  required  in  "1"8 populations  for 
suppression of CTL induction to occur. We have repeated these experiments in our 
system  and  in  several  experiments  have  corroborated  a  -->90% reduction  in  the 
quantity ofCTL effector induction, through at least 144 h culture, in MLC stimulated 
by heated allogeneic cells (e.g., see Table IV). When examined in our Thy-1 congenic 
system, we have found that, as in pyrilamine-treated MLC-generated cells, potent Ts- 
insensitive CTL-PA activity remains in these cultures. This conclusion stems from the 
results of two consecutive experiments  (one of which  is  portrayed in Table V),  in 
which first MLC-derived cells became CTL effectors following transfer to a second, 
fresh MLC. The addition of pyrilamine to cultures containing heated stimulator cells 
prevented detectable generation of CTL-PA in the first culture, whereas T~ function 
persisted (Table V). This result is particularly important because it shows that CTL- 
PA  (i.e.,  activated  cells  capable  of differentiating to  CTL)  are  not  required  for 
suppression of CTL-PN. Whether the effects of combining pyrilamine treatment and 
heat-inactivated stimulator cells are merely additive at the same site of action or act 
on two different sites on the pathway to differentiation is unknown. 
Cellular Requirements  for CTL-PA Differentiation to CTL.  Following transfer ofpyril- 
amine-treated  or  heated  stimulator-induced  MLC-derived  cells  to  fresh  cultures, 
differentiation of first culture CTL-PA to CTL occurs. The next question asked was, 
what cellular elements contributed by the second MLC are required to cause CTL- 
PA  differentiation  to  CTL?  We  found  that  merely  exposing  CTL-PA  to  fresh 
stimulator cells is not sufficient (Table VI, experiment  1). As shown in Table VII, 
fresh responder cells alone are likewise insufficient, but if fresh stimulator cells also 
are added, CTL-PA differentiate to CTL in a stimulator cell dose-dependent manner. 
These stimulator  cells need  not  be  identical  to  those  used  to  prime  the  CTL-PA 
(Table VI, experiment 2). Therefore, step 2 in CTL-P to CTL differentiation requires 
a nonspecific signal provided by a fresh MLC. 
Responder Cell Sets Required  for CTL-PA Differentiation to CTL.  We next explored the 
nature  of second MLC  responder cell populations  necessary for CTL-PA to CTL 
differentiation.  In  experiments  presented  in  Table  VIII,  B6.PLThyl  a  (Thy-l.1  +) 
responder cells were used  in  the  first  MLC  and  B6  (Thy-l.2  +)  in  the second, the 
reverse of most  previous experiments. Therefore, in  this case,  treatment with anti- 
Thy-l.2 antibodies +  C' after the second MLC left only first MLC-derived CTL. As 
shown in experiment  1, twice-passed nylon-nonadherent spleen cells  (depleted of B 
cells and accessory cells, and highly enriched for T  cells) failed to generate a primary 
CTL response upon exposure to alloantigen, yet supported a  decreased (compared 
with untreated responder cells) but significant level of  CTL-PA to CTL differentiation. 
Twice-treated glass-nonadherent cells (depleted of accessory cells), produced less than 
one third the primary CTL response of untreated responder cells and supported a 
similarly decreased amount of CTL-PA to CTL differentiation as twice-passed nylon 
nonadherent cells.  On  the other hand, as demonstrated in experiment 2, anti-Thy- 
1.2-treated cells (depleted ofT cells)  failed to make either a primary CTL response or 
to support CTL-PA differentiation to CTL. These data show that responding popu- 
lations  probably supply at  least  two  important  cellular constituents  necessary for 
CTL-PA differentiation to CTL: T  cells and glass and nylon wool-adherent accessory 
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TABLE VI 
Reculture of MLC-derived CTL-PA: Requirement  for Fresh Responder vs. Stimulator Cells  for 
Differentiation of CTL-PA to CTL * 
Cell number  Cells from first MLC  transferred 
Fresh cells second 
culture 
Re- 
Stimulators  spon- 
ders 
Percent 51Cr release (+ SD) 
PEC target cells 
DBA/2  CBA 
Experiment 1 
B6 a DBA/2 
B6 a DBA/2 + P§ 
ax  1#  5x  1# 
--  DBA/2  B6  22.7 (3.6)  -1.4 (1.8) 
5 X 10  e  0  0  12.2 (0.6)  ND, 
5 X l0  s  DBA/2  0  14.3 (2.4)  ND 
5 X l0  s  0  0  --1.4 (3.1)  ND 
5 X l0  s  DBA/2  0  2.1 (1.8)  ND 
Experiment 2 
B6 a DBA/2 
B6 a DBA/2 + P 
--  CBA  B6  9.7 (1.2)  45.5 (6.1) 
1 x  10  °  0  0  3.0  (3.6)  ND 
1 X 108  CBA  B6  28.5 (2.7)  ND 
2.5 ×  106  CBA  B6  25.6 (4.6)  ND 
1 x  106  0  0  1.7  (3.2)  ND 
1 x  108  CBA  B6  19.2 (2.9)  ND 
2.5 ×  105  CBA  B6  7.4 (3.3)  ND 
* B6-anti-DBA/2 spleen cell MLC, established in triplicate with or without  10  -4  M pyrilamine, were 
harvested after 5 d and were transferred in triplicate as shown to fresh culture medium with or without 
fresh responders and/or mitomycin C-treated stimulators. 5 d later, cells were harvested, diluted equally, 
and tested for cytotoxicity in a culture yield-equivalent manner. 
Not done. 
§ 10-' M pyrilamine. 
Discussion 
These studies have demonstrated that the generation of allospecific CTL occurs in 
two steps. In the first step CTL-PN become activated, and in the second step CTL- 
PA differentiate to functional effector cells. This analysis was facilitated by (a) the use 
of the  histamine1 antagonist, pyrilamine, or  heat-inactivated stimulators to  block 
CTL generation but not suppressor generation, and (b) a system involving  transfer of 
MLC-derived cells into a  second MLC, containing Thy-1 congenic responders and 
homologous stimulators. Pyrilamine-treated or heated stimulator-induced, MLC-de- 
rived cells, which contain few or no detectable CTL, were discovered to differentiate 
into CTL upon transfer to a  second, fresh MLC. In addition, CTL generation in the 
second MLC was suppressed completely when as few as 1 to 2 ×  105 cells, containing 
both suppressor and CTL-PA activities, were transferred per 5 X  10  e fresh responders. 
The presence of either detectable CTL-PA or CTL was not necessary to the occurrence 
of "Is activity (Table V). 
An  uninteresting explanation for  these  data  is  that  the  already  activated  cells 
derived from  the  first  MLC  simply "crowd"  the second MLC  in some nonspecific 
manner,  not  related  to  suppressor  T  cells.  The  result  is  that  the  second  MLC 
responding cell population cannot differentiate optimally into CTL. However, in a 
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TABLE  VII 
Requirement for Stimulator  Cells to Support Differentiation of CTL-PA to 
CTL * 
Second culture 
Pyrilamine-  stimulators 
treated Thy-  x  10  -s added to 
1:2  + cells from  5 X 10  s Thy-l.1 +  first MLC  responders 
Percent SlCr release (+ SD) 
Serum treatment before CTL assay 
NMS +  C'  Anti-Thy-l.2 +  C" 
-  0  -  1.2  (2.1)  ND:~ 
-  5  37.3 (1.2)  41.6 (3.2) 
+  0  -0.3 (2.1)  -0.2 (3.6) 
+  1.25  11.6 (2.7)  -3.5 (2.8) 
+  5  14.8 (1.3)  -0.7 (2.6) 
+  20  25.4 (3.8)  -0.6 (2.0) 
+  80  34.6 (2.0)  2.6 (1.3) 
* B6 (Thy-1.2+)-anti-DBA/2 ML  C were established in the presence or absence 
of 10  4  M pyrilamine for 5 d. Harvested cells were then washed and 2 ×  105 
cells were transferred to six fresh second MLC/group, of B6.PLThy-1 a (Thy- 
1.1 +) responders and DBA/2 stimulators. After 5 d culture, harvested cells 
were divided into two equal aliquots, which were treated with either NMS 
+ C' or anti-Thy- 1.2 serum + C'. Aliquots were then washed, diluted equally, 
and tested in quadruplicate for ability to kill 2 ×  104 P815 target cells, at a 
37:1 effector/target cell ratio. 
Not done. 
TABLE  VIII 
Responder Cell Populations Required for Differentiation of CTL-PA to CTL* 
Cells from first MLC  Fresh reaponder cells in second 
Number of  MLC 
cells trans- 
ferred 
Percent  tilCr release (5 SD) at culture dilution 
Treatment of effcetors before CTL assay 
1:3  Undiluted 
Responders  Conditions  Phenotype  Pre-treatment:~  Medium  Anti-Thy-  Medium  Anti-Thy- 
+  C'  1.2 +  C'  +  C'  1.2 +  C' 
Experiment  1 
--  --  0  Thy-l.2 +  None  46.1  (4.6)  4.7  (3.9)  64,8 (7.1)  17.7  (4.2) 
Thy-1 1  +  +  P  5 ×  l0  s  Thy-l.2*  None  19.2 (3.6)  19.0 (4.9)  39.8 (5.6)  36.9 (2.2) 
--  --  0  Thy-l.2*  Nylon  -0.4 (1.7)  -0.5 (0.6)  -l.5  (4.1)  E2 (4.3) 
Thy-1  1  +  +  P  5 ×  l0  s  Thy-l.2  +  Nylon  2.0 (5.2)  4.1  (3.7)  12.4 (4.5)  9.4 (4.8) 
--  --  0  Thy-1.2 +  Glass  10.9 (1.1)  -3.8 (3.6)  27.0 (2.3)  0.2 (4.0) 
Thy, l.l +  +  P  5 ×  l0  B  Thy-l.2 +  Glass  3.1  (4.1)  3.2 (6.3)  13.8 (I.7)  11.6 (4.3) 
Experiment 2 
--  --  0  Thy-l.2 +  Medium +  C'  27.7 (2.1)  -1.2  (2.2)  40.6 (2.0)  0.5 (1.9) 
Thy-l.l +  +  P  5 ×  10  ~  Thy-l.2 +  Medium +  C'  6.7 (2.0)  3.5 (4.2)  13.3 (1.0)  l l.l  (5.7) 
--  --  0  Thy-l.2 +  Anti-Thy-l.2 +  C"  0.5 (3.6)  0,8 (2.1)  --1.8 (1.3)  4,0 (2 l) 
Thy-l.I +  +  P  5 ×  l0  s  Thy-l.2 +  Anti-Thy-l.2 +  C'  -0.1  (2.9)  --2.8 (3.2)  3.5 (2.3)  4.5 (4.7) 
* First and second anti-DBA/2 MLC were established, and transfers and assays were performed as described in the legend of Table If, except 
that first MLC responder cells were B6.PLThyI"  (Thy-l.1 +) and second culture responder cells were B6 (Thy-l.2+). Target cells were P815. 
:~ Second culture r~ponder spleen cells were treated before culture by twice depleting nylon wool adherent cells (23% yield), by twice depleting 
glass adherent cells (70% yield), or by incubating with either medium or with anti-Thy-l.2 hybridoma reagent +  C' (65% yield compared to 
medium +  C' treatment).  5 X  106 of each type of responder cell were added to 5 ×  l0  s siimulator cells 
Sutton,  and  R.  K.  Gershon,  submitted  for publication),  we  have  shown  that  under 
the  conditions  used  in  the  current  study  (a)  suppression  is  completely  removed  by 
treatment  with anti-Thy-1  antibody  plus complement  and  (b) alloantigen  specificity 
can  be  demonstrated  for  these  T8  (e.g.,  pyrilamine-treated,  H-2b-anti-H-2 a  MLC- 
derived cells could suppress  CTL  generation  by responding  H-2  b cells stimulated  by A. SCHWARTZ,  S.  L.  SUTTON, AND  R.  K.  GERSHON  793 
H-2  d antigens, whereas, simuhaneously, they had little or no effect on CTL generation 
by H-2  b cells stimulated  by H-2  k antigens).  Therefore, the above trivial explanation 
for our results  is ruled  out. This  leaves us with  the conclusion that  the CTL-PN  to 
CTL-PA step is pyrilamine-resistant, can occur when heated stimulator cells are used 
and  is  suppressor  T  cell-sensitive,  while  the  CTL-PA  to  CTL  step  is  pyrilamine- 
sensitive, cannot occur when heated stimulator cells are used and is suppressor T  cell 
resistant  (see  Fig.  1).  Our  data  also show  that  the  differentiation  step  requires  the 
interaction  of CTL-PA  with  a  nonspecific  signal  from  fresh,  alloantigen-induced, 
responding T  cells and accessory cells. 
Findings not presented  here imply that  the effects of pyrilamine studied  might be 
primarily  due  to  its  local  anesthetic  capability,  and  not  its  histamine1  receptor 
antagonist  function,  although  the  true  mechanism  of its  action  remains  unknown, 
and is irrelevant to the message of this paper. 
Th activity is required for optimal induction of CTL (7). The antigens required for 
stimulation  of Th for CTL responses are sensitive  to heat  inactivation  (14), whereas 
C~I'L-P are  triggered  to  become Th-responsive  (14)  and  Ta  are  induced  (9)  under 
identical  conditions.  We  have  found  that  as  in  pyrilamine-treated  MLC,  heated 
stimulator-induced  CTL-PN  become  CTL-PA,  which  are  T,-insensitive.  By  also 
adding pyrilamine to such cultures,  differentiation  to CTL subsequent  to transfer is 
prevented  (Table  V).  This  implies  either  that  pyrilamine  is  blocking  a  different 
component in CTL-P activation from that prevented by use of heated stimulators, or 
that  the block in CTL-P differentiation  is the same, but  is made more complete by 
combined treatment with.pyrilamine. 
Studies from several laboratories have shown that at least two different Th interact 
in the production of an optimal  B cell  response  (1-6).  Rohrer et  al.  (manuscript  in 
preparation),  have recently  found  that  two  different  Lyt-l+23  -  Th  populations  are 
needed for the proliferation and then the secretion of antibody by malignant  B cells 
clones. These Th are Qal-  and Qal ÷, respectively.  In addition,  Eichmann et  al.  (6) 
have  shown,  by  limiting  dilution  analysis,  that  one  of  two  B  cell-inducing  Th 
populations  in their system, is present  in  large numbers,  is probably a  Th precursor 
cell  and  is sensitive  to the effects of suppressor cells.  In contrast,  a  second Th exists 
which  appears  more  mature,  is  present  in  smaller  numbers  and  is  resistant  to 
suppression.  Similarly, Green et  al.  (16), using an intermediate  culture system, have 
subdivided  Ly-1 Th subsets by virtue of their different sensitivities  to suppression. 
More cogent to our studies are the findings of Goronzy et  al.  05), demonstrating 
activation  diffecentiatlon 
CTL-PN  .CTL-PA  ~  CTL 
1)  Th  cell dependent  9 "  1) T  h celt ¢feDendent 
2)  Pynklmlne relllatsnt  2)  Py~emlne sensitive 
3)  lnduc!ble by heot-!nscfivated  3) Not inducible by heat-in41ctivated 
stimulator coils  stimulator ceils 
4)  8ugoression sensitive  4) ~.¢oresldon reldotln! 
Ftc.  1.  Two steps in the differentiation of CTL-P to CTL. The apparent inability of CTL-PN to 
be induced to CTL-PA in  the presence of suppressor cells that  do not prevent CTI.-PA  from 
becoming CTL effector cells could be due either to qualitative or quantitative  differences in their 
sensitivity to suppression. (o) In preliminary experiments the CTL-PN to CTL-PA step was found 
to depend on the presence of Lyt-I  "~ cells for optimal induction (data not presented). 794  TWO  STEPS  IN  CYTOTOXIC  T  LYMPHOCYTE  INDUCTION 
that  in polyclonally activated T  cell populations, two different CTL-P are present, 
one of which  is  frequent, sensitive to suppression,  and  probably less  mature  (Lyt- 
1+23+), and a second, which is rare, resistant to suppression, and phenotypically more 
mature (Lyt-l-23+). These and other findings might be interpreted to indicate that 
their two populations might be primary (naive) and secondary (activated or "mem- 
ory") precursors respectively. Because the CTL-PN and CTL-PA activities we have 
described here have differential functional characteristics similar to these frequent 
and rare CTL-P, respectively, is it possible that we have demonstrated an arrest in 
CTL production that allows memory to be activated in the absence of prior demon- 
strable effector function? 
That the CTL-PN to CTL-PA step is alloantigen specific, whereas CTL differen- 
tiation is not, is inferred from experiments showing that the culture into which the 
CTL-PA  are  transferred  does  not  have  to  contain  stimulators  bearing  the  same 
alloantigen as in the first MLC, although first culture antigen specificity is maintained 
(Table VI). The second culture appears to provide a non-antigen-specific lymphokine, 
such as interleukin 2, which is responsible for CTL-PA to CTL differentiation. The 
latter  lymphokine is  produced  in  the  presence of adherent  ceils  (17)  by antigen- 
activated or polyclonally activated  Lyt-l+23  -  cells and  can  cause only previously 
antigen-stimulated or polyclonally activated CTL-P (18-20) or Lyt- 1  +23 + thymocyte 
CTL-P (21)  to differentiate to CTL. In accord with this possibility, we have found 
that pyrilamine-treated CTL-PA fail to become effectors until 2-3 d after transfer to 
the second MLC  (data not  presented), and  that  fresh T  cells, adherent  cells, and 
antigen are required for optimal differentiation of CTL-PA to CTL (present study). 
One explanation for our data is that  a  different Th is required for activation of 
CTL-PN to CTL-PA than that required for the CTL-PA to CTL step and that the 
dissimilar pyrilamine, heated stimulator, and suppressor T  cell sensitivities of the two 
Th are actually what  are being measured. The CTL-PA to CTL step is clearly Th 
dependent.  The  CTL-PN  to  CTL-PA  step  is  currently  under  investigation.  In 
preliminary studies (data not presented) we have found that the CTL-PN to CTL-PA 
step may require the presence of Lyt-1  + cells for optimal induction. This being the 
case, another analogy exists between CTL and B cells, in that Keller and colleagues 
(22)  have described two Th for antibody formation, the second and  late acting of 
which is antigen specific in its ability to be triggered but non-antigen specific in its 
delivery of a helper signal. 
The data presented here provide additional evidence that the cellular interactions 
involved in regulation of CTL generation and of B cell function are similar, and that 
the steps in the development of effector cells in these two major arms of the immune 
system utilize conserved activating and differentiative events. Many of the unanswered 
questions raised here should be approachable by using the described methodology as 
an investigative tool. 
Summary 
The differentiation of cytotoxic T  lymphocyte precursor cells (CTL-P) into CTL 
effector cells is a two-step process. In the first step, naive CTL-P (CTL-PN) become 
activated (CTL-PA) but do not yet have the capacity to kill target cells. CTL-PA can 
be distinguished from CTL-PN because the former are far less sensitive than the latter 
to the effects of in vitro-generated suppressor cells. Thus, the addition of suppressor T A.  SCHWARTZ,  S.  L.  SUTTON, AND R.  K.  GERSHON  795 
cells  (Ts)  to a  fresh MLC can totally inhibit  the production of CTL from CTL-PN, 
whereas the same T, only minimally affect the generation of CTL from CTL-PA. It 
is not known whether these "Is act directly on CTL-PN or on a  helper cell needed for 
activation to CTL-PA. The production of CTL-PA can take place in allogeneic mixed 
leukocyte cultures (MLC) treated with the drug pyrilamine, or when heat-inactivated 
stimulator cells are used. Each of these treatments inhibits the differentiation of CTL- 
PA to CTL.  However,  if pyrilamine  is  removed,  a  nonspecific MLC-derived  signal 
can induce these CTL-PA to become CTL, even in the presence of significant numbers 
of T,. This two step process of differentiation of CTL-P to CTL may be analogous to 
the way na'ive B cells become antibody-producing ceils. 
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